N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy

MLA

George Salvatore Amato, et al. “N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy.” ACS Medicinal Chemistry Letters, vol. 2, no. 6, Feb. 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....aecd7eba39cc0d236d7c10115372ec65&authtype=sso&custid=ns315887.

APA

George Salvatore Amato, Mark J. Suto, Brett Antonio, Theresa Mersch, Paul Christopher Fritch, Alan D. Wickenden, Grant Andrew Mcnaughton-Smith, Greg C. Rigdon, & Rosemarie Roeloffs. (2011). N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy. ACS Medicinal Chemistry Letters, 2(6).

Chicago

George Salvatore Amato, Mark J. Suto, Brett Antonio, Theresa Mersch, Paul Christopher Fritch, Alan D. Wickenden, Grant Andrew Mcnaughton-Smith, Greg C. Rigdon, and Rosemarie Roeloffs. 2011. “N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy.” ACS Medicinal Chemistry Letters 2 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....aecd7eba39cc0d236d7c10115372ec65&authtype=sso&custid=ns315887.